Nektar Therapeutics (NKTR)
57.68
-1.10
(-1.88%)
USD |
NASDAQ |
Dec 10, 16:00
57.66
-0.02
(-0.03%)
After-Hours: 17:46
Nektar Therapeutics Total Assets (Quarterly): 301.35M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Amicus Therapeutics, Inc. | 868.81M |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Rigel Pharmaceuticals, Inc. | 242.53M |
| Zevra Therapeutics, Inc. | 270.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 216.26M |
| Shareholders Equity (Quarterly) | 85.09M |
| Debt to Equity Ratio | 1.964 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 1.07% |